Kathy V. Turner - Feb 14, 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Kathy V. Turner
Stock symbol
IDXX
Transactions as of
Feb 14, 2023
Transactions value $
-$997,678
Form type
4
Date filed
2/16/2023, 05:56 PM
Previous filing
Feb 13, 2023
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +210 +3.03% $0.00 7.15K Feb 14, 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +181 +2.53% $0.00 7.33K Feb 14, 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +162 +2.23% $0.00 7.44K Feb 14, 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +86 +1.15% $0.00 7.58K Feb 14, 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +93 +1.23% $0.00 7.67K Feb 14, 2023 Direct
transaction IDXX Common Stock Tax liability -$148K -293 -3.82% $503.65 7.38K Feb 14, 2023 Direct
transaction IDXX Common Stock Options Exercise $159K +2K +27.1% $79.54* 9.38K Feb 14, 2023 Direct
transaction IDXX Common Stock Sale -$505K -1K -10.66% $505.06 8.38K Feb 14, 2023 Direct F1
transaction IDXX Common Stock Sale -$158K -313 -3.74% $504.66 8.07K Feb 14, 2023 Direct F2
transaction IDXX Common Stock Sale -$291K -577 -7.15% $504.09 7.49K Feb 14, 2023 Direct F3
transaction IDXX Common Stock Sale -$55.3K -110 -1.47% $502.81 7.38K Feb 14, 2023 Direct F4
holding IDXX Common Stock 100 Feb 14, 2023 by spouse F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -210 -13.77% 1.32K Feb 14, 2023 Common Stock 210 Direct F6, F12
transaction IDXX Restricted Stock Unit Options Exercise -181 -13.76% 1.13K Feb 14, 2023 Common Stock 181 Direct F7, F12
transaction IDXX Restricted Stock Unit Options Exercise -162 -14.29% 972 Feb 14, 2023 Common Stock 162 Direct F8, F12
transaction IDXX Restricted Stock Unit Options Exercise -86 -8.85% 886 Feb 14, 2023 Common Stock 86 Direct F9, F12
transaction IDXX Restricted Stock Unit Options Exercise -93 -10.5% 793 Feb 14, 2023 Common Stock 93 Direct F10, F12
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -2K -29.69% 4.74K Feb 14, 2023 Common Stock 2K $79.54 Direct F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold ranging from a low of $505.00 to a high of $505.225 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average price of the shares sold ranging from a low of $504.49 to a high of $504.75 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $503.43 to a high of $504.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $502.42 to a high of $503.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
F6 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F9 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F10 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F11 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,993 shares in five annual installments beginning February 15, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F12 Not applicable.